Literature DB >> 2120340

Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-gamma is inhibited by selective depletion of neutrophils with a monoclonal antibody.

Y Abe1, S Sekiya, T Yamasita, F Sendo.   

Abstract

We investigated whether various recombinant cytokines induce vascular hyperpermeability when intradermally injected into rats. Only TNF did so. Of the other cytokines examined (IL-1, IL-2, granulocyte-CSF, IFN-alpha, IFN-beta, IFN-gamma) none had this effect. The increase in vascular permeability was dose dependent, and the peak response was observed at 90 min after TNF injection. When mixtures of TNF and various other cytokines (IL-1, IL-2, granulocyte-CSF, IFN-alpha, IFN-beta, IFN-gamma) were injected, only IL-1 and IFN-gamma augmented TNF-induced vascular hyperpermeability, the increase occurring in a dose-dependent manner. The induction of vascular hyperpermeability by TNF and its enhancement by IL-1 and IFN-gamma were inhibited by selective depletion of peripheral blood neutrophils with i.p. administration of an anti-rat neutrophil mAb, RP-3. Reconstitution of neutrophils to the depleted rats by in situ injection of these cells, restored TNF increased vascular permeability.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells.

Authors:  Sybill Thomas-Ecker; Antje Lindecke; Wolfgang Hatzmann; Christian Kaltschmidt; Kurt S Zänker; Thomas Dittmar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

Review 3.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

4.  Hypoxia aggravates lipopolysaccharide-induced lung injury.

Authors:  D Vuichard; M T Ganter; R C Schimmer; D Suter; C Booy; L Reyes; T Pasch; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Src-family kinase-p53/ Lyn p56 plays an important role in TNF-alpha-stimulated production of O2- by human neutrophils adherent to fibrinogen.

Authors:  S R Yan; M J Novak
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

6.  Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.

Authors:  J Klingström; A Plyusnin; A Vaheri; A Lundkvist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Role of neutrophils in the pathogenesis of experimental vasculitis.

Authors:  F J Qasim; P W Mathieson; F Sendo; S Thiru; D B Oliveira
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

8.  Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.

Authors:  S Gatti; R Faggioni; B Echtenacher; P Ghezzi
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Upregulation of IFN-γ and IL-12 is associated with a milder form of hantavirus hemorrhagic fever with renal syndrome.

Authors:  S F Khaiboullina; E V Martynova; Z L Khamidullina; E V Lapteva; I V Nikolaeva; V V Anokhin; V C Lombardi; A A Rizvanov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-19       Impact factor: 3.267

10.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.